US Stock MarketDetailed Quotes
BIOA BioAge Labs
- 24.120
- +2.420+11.15%
Close Oct 14 16:00 ET
- 24.200
- +0.080+0.33%
Post 18:59 ET
863.91MMarket Cap-13066P/E (TTM)
24.850High21.800Low653.12KVolume21.970Open21.700Pre Close15.19MTurnover6.22%Turnover RatioLossP/E (Static)35.82MShares24.85052wk High-4.38P/B253.26MFloat Cap18.30052wk Low--Dividend TTM10.50MShs Float24.850Historical High--Div YieldTTM14.06%Amplitude18.300Historical Low23.259Avg Price1Lot Size
BioAge Labs Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||
| Gross profit | ||||||
| Operating expense | 13.85%15.27M | 11.37%12.81M | 21.09%48.4M | 13.41M | 11.51M | 39.97M |
| Selling and administrative expenses | 14.84%4.8M | 0.72%3.49M | 53.64%14.51M | --4.18M | --3.47M | --9.45M |
| -General and administrative expense | 14.84%4.8M | 0.72%3.49M | 53.64%14.51M | --4.18M | --3.47M | --9.45M |
| Research and development costs | 13.40%10.47M | 15.96%9.32M | 11.02%33.89M | --9.23M | --8.04M | --30.52M |
| Operating profit | -13.85%-15.27M | -11.37%-12.81M | -21.09%-48.4M | -13.41M | -11.51M | -39.97M |
| Net non-operating interest income expense | 202.15%1.76M | -82.13%79K | -2,494.20%-5.36M | -1.72M | 442K | 224K |
| Non-operating interest income | 592.14%2.2M | 4.94%1.3M | 422.80%2.43M | --318K | --1.24M | --465K |
| Non-operating interest expense | -78.27%443K | 53.47%1.22M | 3,134.02%7.79M | --2.04M | --793K | --241K |
| Other net income (expense) | 96.59%-70K | -1,128.57%-258K | -43,973.91%-10.09M | -2.05M | -21K | 23K |
| Gain on sale of security | 96.59%-70K | 61.90%-8K | -43,973.91%-10.09M | ---2.05M | ---21K | --23K |
| Special income (charges) | --0 | ---250K | ---- | --0 | --0 | ---- |
| -Less:Other special charges | --0 | --250K | ---- | ---- | ---- | ---- |
| Income before tax | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | -17.19M | -11.08M | -39.72M |
| Income tax | ||||||
| Net income | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | -17.19M | -11.08M | -39.72M |
| Net income continuous Operations | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | ---17.19M | ---11.08M | ---39.72M |
| Minority interest income | ||||||
| Net income attributable to the parent company | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | -17.19M | -11.08M | -39.72M |
| Preferred stock dividends | ||||||
| Other preferred stock dividends | ||||||
| Net income attributable to common stockholders | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | -17.19M | -11.08M | -39.72M |
| Basic earnings per share | 53.47%-0.3975 | 30.98%-0.3802 | 69.11%-7.34 | -0.8542 | -0.5509 | -23.76 |
| Diluted earnings per share | 53.47%-0.3975 | 30.98%-0.3802 | 69.11%-7.34 | -0.8542 | -0.5509 | -23.76 |
| Dividend per share | ||||||
| Currency Unit | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
